Cargando…

The determinants of COVID-19 morbidity and mortality across countries

We identify 21 predetermined country-level factors that explain marked variations in weekly COVID-19 morbidity and mortality across 91 countries between January and the end of 2020. Besides factors commonly associated with infectious diseases (e.g., population and tourism activities), we discover a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Dianna, Chang, Xin, He, Yu, Tan, Kelvin Jui Keng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989117/
https://www.ncbi.nlm.nih.gov/pubmed/35393471
http://dx.doi.org/10.1038/s41598-022-09783-9
_version_ 1784683096465997824
author Chang, Dianna
Chang, Xin
He, Yu
Tan, Kelvin Jui Keng
author_facet Chang, Dianna
Chang, Xin
He, Yu
Tan, Kelvin Jui Keng
author_sort Chang, Dianna
collection PubMed
description We identify 21 predetermined country-level factors that explain marked variations in weekly COVID-19 morbidity and mortality across 91 countries between January and the end of 2020. Besides factors commonly associated with infectious diseases (e.g., population and tourism activities), we discover a list of country characteristics that shape COVID-19 outcomes. Among demographic–geographic factors, the male-to-female ratio, population density, and urbanization aggravate the severity of COVID-19, while education, temperature, and religious diversity mitigate the impact of the pandemic on morbidity and mortality. For the political-legal dimension, democracy and political corruption are aggravating factors. In contrast, female leadership, the strength of legal systems, and public trust in government significantly reduce infections and deaths. In terms of socio-economic aspects, GDP per capita, income inequality, and happiness (i.e., life satisfaction) lead to worse COVID-19 outcomes. Interestingly, technology advancement increases morbidity but reduces mortality. For healthcare factors, SARS (severe acute respiratory syndrome) experience and healthcare infrastructure help countries perform better in combating the pandemic.
format Online
Article
Text
id pubmed-8989117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89891172022-04-11 The determinants of COVID-19 morbidity and mortality across countries Chang, Dianna Chang, Xin He, Yu Tan, Kelvin Jui Keng Sci Rep Article We identify 21 predetermined country-level factors that explain marked variations in weekly COVID-19 morbidity and mortality across 91 countries between January and the end of 2020. Besides factors commonly associated with infectious diseases (e.g., population and tourism activities), we discover a list of country characteristics that shape COVID-19 outcomes. Among demographic–geographic factors, the male-to-female ratio, population density, and urbanization aggravate the severity of COVID-19, while education, temperature, and religious diversity mitigate the impact of the pandemic on morbidity and mortality. For the political-legal dimension, democracy and political corruption are aggravating factors. In contrast, female leadership, the strength of legal systems, and public trust in government significantly reduce infections and deaths. In terms of socio-economic aspects, GDP per capita, income inequality, and happiness (i.e., life satisfaction) lead to worse COVID-19 outcomes. Interestingly, technology advancement increases morbidity but reduces mortality. For healthcare factors, SARS (severe acute respiratory syndrome) experience and healthcare infrastructure help countries perform better in combating the pandemic. Nature Publishing Group UK 2022-04-07 /pmc/articles/PMC8989117/ /pubmed/35393471 http://dx.doi.org/10.1038/s41598-022-09783-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chang, Dianna
Chang, Xin
He, Yu
Tan, Kelvin Jui Keng
The determinants of COVID-19 morbidity and mortality across countries
title The determinants of COVID-19 morbidity and mortality across countries
title_full The determinants of COVID-19 morbidity and mortality across countries
title_fullStr The determinants of COVID-19 morbidity and mortality across countries
title_full_unstemmed The determinants of COVID-19 morbidity and mortality across countries
title_short The determinants of COVID-19 morbidity and mortality across countries
title_sort determinants of covid-19 morbidity and mortality across countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989117/
https://www.ncbi.nlm.nih.gov/pubmed/35393471
http://dx.doi.org/10.1038/s41598-022-09783-9
work_keys_str_mv AT changdianna thedeterminantsofcovid19morbidityandmortalityacrosscountries
AT changxin thedeterminantsofcovid19morbidityandmortalityacrosscountries
AT heyu thedeterminantsofcovid19morbidityandmortalityacrosscountries
AT tankelvinjuikeng thedeterminantsofcovid19morbidityandmortalityacrosscountries
AT changdianna determinantsofcovid19morbidityandmortalityacrosscountries
AT changxin determinantsofcovid19morbidityandmortalityacrosscountries
AT heyu determinantsofcovid19morbidityandmortalityacrosscountries
AT tankelvinjuikeng determinantsofcovid19morbidityandmortalityacrosscountries